| Assay ID | Title | Year | Journal | Article |
|---|
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID1797314 | Fluorescence Exchange Curve Assay from Article 10.1038/nsb770: \\Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site.\\ | 2002 | Nature structural biology, Apr, Volume: 9, Issue:4
| Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. |
| AID1797315 | Fluorescence Exchange Curve Assay from Article 10.1021/jm030120s: \\Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.\\ | 2003 | Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
| Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors. |
| AID127262 | Rate of association to Mitogen-activated protein kinase p38 alpha | 2003 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 13, Issue:18
| The kinetics of binding to p38MAP kinase by analogues of BIRB 796. |
| AID127261 | Rate of dissociation from Mitogen-activated protein kinase p38 alpha | 2003 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 13, Issue:18
| The kinetics of binding to p38MAP kinase by analogues of BIRB 796. |
| AID127260 | Binding affinity for Mitogen-activated protein kinase p38 alpha | 2003 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 13, Issue:18
| The kinetics of binding to p38MAP kinase by analogues of BIRB 796. |
| AID445088 | Inhibition of p38alpha active form expressed in Escherichia coli BL21(DE3) cells by HTRF assay | 2010 | Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
| Displacement assay for the detection of stabilizers of inactive kinase conformations. |
| AID127252 | Dissociation constant at Tref against human Mitogen-activated protein kinase p38 alpha | 2003 | Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
| Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors. |
| AID127249 | Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha | 2003 | Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
| Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors. |
| AID445087 | Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of p38alpha expressed in Escherichia coli BL | 2010 | Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
| Displacement assay for the detection of stabilizers of inactive kinase conformations. |
| AID1380351 | Inhibition of p38alpha (unknown origin) | 2018 | Journal of medicinal chemistry, 08-09, Volume: 61, Issue:15
| Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. |
| AID127076 | Binding affinity for human recombinant Mitogen-activated protein kinase p38 in a fluorescent binding assay | 2002 | Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
| Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. |
| AID127079 | Evaluated for inhibition of human mitogen-activated protein kinase p38 | 2004 | Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
| General model for estimation of the inhibition of protein kinases using Monte Carlo simulations. |
| AID513128 | Inhibition of p38alpha kinase | 2006 | Nature chemical biology, Jul, Volume: 2, Issue:7
| Rational design of inhibitors that bind to inactive kinase conformations. |
| AID127251 | Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (fluorescence exchange curve) | 2003 | Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
| Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors. |
| AID209191 | Inhibition of LPS-induced tumor necrosis factor-alpha (TNF-alpha) production in THP-1 cells | 2002 | Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
| Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. |
| AID127250 | Dissociation constant at Tm against human Mitogen-activated protein kinase p38 alpha (constant fit) | 2003 | Journal of medicinal chemistry, Oct-23, Volume: 46, Issue:22
| Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors. |
| AID1811 | Experimentally measured binding affinity data derived from PDB | 2002 | Nature structural biology, Apr, Volume: 9, Issue:4
| Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. |
| AID977611 | Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB | 2002 | Nature structural biology, Apr, Volume: 9, Issue:4
| Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. |
| AID493017 | Wombat Data for BeliefDocking | 2002 | Journal of medicinal chemistry, Jul-04, Volume: 45, Issue:14
| Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate. |
| AID977611 | Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB | 2004 | Journal of medicinal chemistry, May-06, Volume: 47, Issue:10
| General model for estimation of the inhibition of protein kinases using Monte Carlo simulations. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |